You are here

Clinical Trials: Nervous System Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, August 6, 2012 - 12:00
Condition:   Stable Angina
Interventions:   Biological: intramyocardial injection (electromechanical mapping based);   Biological: Placebo
Sponsor:   Medical University of Silesia
Recruiting - verified April 2016
Posted: Tuesday, July 10, 2012 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Procedure: skin biopsy
Sponsor:   Institut Pasteur
Recruiting - verified December 2012
Posted: Thursday, July 5, 2012 - 12:00
Condition:   POEMS Syndrome
Interventions:   Drug: Lenalidomide and dexamethasone;   Drug: Lenalidomide and dexamethasone
Sponsors:   University Hospital, Limoges;   Ministry of Health, France;   Celgene Corporation
Recruiting - verified March 2015
Posted: Monday, May 21, 2012 - 12:00
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
Condition:   Duchenne Muscular Dystrophy
Intervention:   Biological: human umbilical cord mesenchymal stem cells
Sponsors:   Shenzhen Beike Bio-Technology Co., Ltd.;   The Second Affiliated Hospital of Kunming Medical University
Recruiting - verified November 2012
Posted: Thursday, January 19, 2012 - 12:00
Conditions:   Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention:   Drug: NT-501
Sponsors:   Neurotech Pharmaceuticals;   University of California, San Francisco;   FDA Office of Orphan Products Development
Recruiting - verified March 2016
Posted: Thursday, January 5, 2012 - 12:00
Conditions:   Apgar; 0-3 at 1 Minute;   Metabolic Acidosis;   Hypoxia, Brain;   Multiple Organ Failure
Interventions:   Procedure: Application of Stem Cells;   Procedure: Observation
Sponsor:   Hospital Universitario Dr. Jose E. Gonzalez
Recruiting - verified January 2012

Pages